Riddhi Siddhi Gluco Biols Ltd Falls to 52-Week Low Amidst Weak Financials

Stock Price Movement and Volatility

On 31 Dec 2025, Riddhi Siddhi Gluco Biols Ltd’s share price touched an intraday low of Rs.405, representing a 6.09% drop from its intraday high of Rs.457, which itself was a 5.97% gain from the previous close. Despite this intraday volatility of 6.03%, the stock closed lower, registering a day change of -0.75%. This decline extended a losing streak spanning six consecutive trading sessions, during which the stock has fallen by 8.48% cumulatively.

The stock’s current price is well below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This technical positioning contrasts sharply with the broader market, where the Sensex rose by 0.89% to close at 85,429.51, approaching its 52-week high of 86,159.02.

Comparative Market Performance

While the Sensex and BSE Small Cap indices have shown strength—Small Caps gained 1.16% today—Riddhi Siddhi Gluco Biols Ltd has lagged significantly. Over the past year, the stock has delivered a negative return of 33.02%, in stark contrast to the Sensex’s positive 9.32% gain. The stock’s 52-week high was Rs.691, underscoring the extent of its decline to the current low.

Financial Performance and Fundamental Concerns

The company’s financial metrics have deteriorated over recent periods, contributing to the stock’s weak performance. Riddhi Siddhi Gluco Biols Ltd has reported negative results for three consecutive quarters. Its net sales for the latest quarter stood at Rs.32.10 crores, down 34.36% year-on-year. Profit after tax (PAT) for the nine months ended was Rs.27.63 crores, reflecting a decline of 61.36%. The profit before tax excluding other income (PBT less OI) was negative Rs.4.05 crores, a steep fall of 225.00% compared to the prior period.

The company’s long-term growth has been subdued, with a compound annual growth rate (CAGR) of net sales at -14.03% over the last five years. This weak growth trajectory is compounded by a poor ability to service debt, as indicated by an average EBIT to interest ratio of -1.18. The negative earnings before interest, tax, depreciation and amortisation (EBITDA) further highlight the financial strain.

Valuation and Risk Profile

Riddhi Siddhi Gluco Biols Ltd’s stock is trading at valuations that are considered risky relative to its historical averages. The company’s return on capital employed (ROCE) is negative, reflecting losses and inefficient capital utilisation. Over the past year, profits have fallen by 18.7%, while the stock price has declined by 33.02%, underscoring the disconnect between earnings performance and market valuation.

In addition to underperforming the Sensex, the stock has lagged the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in both the near and long term.

Shareholding and Market Grade

The majority shareholding remains with the company’s promoters, maintaining control despite the stock’s recent performance. The company’s market capitalisation grade is rated 4, while its overall Mojo Score stands at 3.0, with a Mojo Grade of Strong Sell as of 1 February 2025, downgraded from Sell. This grading reflects the company’s deteriorated fundamentals and market sentiment.

Contextualising the Stock’s Performance

Despite a broadly positive market environment, with the Sensex trading above its 50-day moving average and small caps leading gains, Riddhi Siddhi Gluco Biols Ltd’s stock has not participated in this rally. The divergence highlights company-specific factors weighing on investor confidence and valuation.

The stock’s high intraday volatility and consistent trading below all major moving averages suggest that market participants remain cautious. The gap between the current price and the 52-week high of Rs.691 further emphasises the scale of the decline experienced over the past year.

Summary of Key Metrics

To summarise, the stock’s key performance indicators as of 31 Dec 2025 are:

• 52-week low: Rs.405
• 52-week high: Rs.691
• One-year return: -33.02%
• Net sales CAGR (5 years): -14.03%
• PAT (9 months): Rs.27.63 crores, down 61.36%
• PBT less other income (quarterly): -Rs.4.05 crores, down 225.00%
• EBIT to interest ratio (average): -1.18
• Mojo Score: 3.0 (Strong Sell)
• Market Cap Grade: 4

The stock’s performance and financial indicators reflect a challenging period for Riddhi Siddhi Gluco Biols Ltd, with the 52-week low marking a notable point in its recent market journey.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →